Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E expression in localized prostate cancers.

Marco C Venanzoni1, Sergio Giunta, Giovan Battista Muraro

  • 1Laboratory of Molecular Oncology, Laboratory Medicine Department, INRCA, I-Ancona 60100, Italy.

International Journal of Oncology
|March 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological study.

Tissue & cell·2026
Same author

IgG4-related kidney disease presenting as severe renal failure: Diagnostic challenges of a multimodality imaging approach.

Radiology case reports·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Diagnostic, Prognostic, and Predictive Tissue Biomarkers in Urothelial Carcinoma In Situ: A Narrative Review.

Diagnostics (Basel, Switzerland)·2025
Same author

Machine Learning Approach Identifies miRNA Biomarkers for Post Surgical Patient Stratification in Prostate Cancer.

The Prostate·2025
Same author

Effect of natural compounds on NRF2/KEAP1 signaling in periodontitis: a potential use to prevent age-related disorders.

Molecular biology reports·2025

Apolipoprotein E (ApoE) is highly expressed in aggressive prostate cancer cells. This finding suggests ApoE may serve as a biomarker for predicting disease progression and invasiveness in patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer is a leading cause of cancer death in men, with unpredictable progression from localized to metastatic disease.
  • Distinguishing between dormant and progressive prostate cancers is crucial for effective patient management due to treatment-related morbidity.
  • Current methods for predicting prostate cancer progression require improvement.

Purpose of the Study:

  • To investigate gene expression differences between prostate cancer cell lines with varying tumorigenicity.
  • To identify potential biomarkers for aggressive prostate cancer.
  • To evaluate the association of Apolipoprotein E (ApoE) expression with prostate cancer aggressiveness and invasiveness.

Main Methods:

  • Differential display cloning was used to compare gene expression in PC-3, LNCaP, and DU-145 prostate cancer cell lines.

Related Experiment Videos

  • ApoE mRNA expression was quantified in cell lines.
  • ApoE protein expression was assessed in 20 prostatectomy specimens using immunohistochemistry.
  • Correlation between ApoE expression, Gleason score, hormone independence, and invasiveness was analyzed.

    • Main Results:

    • Apolipoprotein E (ApoE) mRNA was found to be highly expressed exclusively in the highly tumorigenic PC-3 cell line.
    • ApoE protein expression in prostatectomy specimens directly correlated with Gleason score.
    • Elevated ApoE expression was associated with hormone independence, local invasiveness, and distant metastasis.
    • ApoE was detected in prostatic intraepithelial neoplasias (PINs) adjacent to tumors, but not in more distant PINs.

    Conclusions:

    • Apolipoprotein E (ApoE) is significantly upregulated in aggressive prostate cancer.
    • ApoE expression serves as a potential biomarker for predicting prostate cancer progression, invasiveness, and hormone independence.
    • ApoE may be an early indicator of malignancy in prostatic intraepithelial neoplasia.